Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|December 5, 2019
CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in MiceFabio F Stellari, Angelo Sala, Francesca Ruscitti, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2006
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparationsCarola Buccellati, Angelo Sala, Giuseppe Rossoni, et al.
Journal of Medicinal Chemistry|October 19, 2019
Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head ChainLaurence Balas, Patrizia Risé, Dayaker Gandrath, et al.
Pharmacological Research|December 2, 2015
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibitionMalvina Hoxha, Carola Buccellati, Valérie Capra, et al.
Frontiers in Pharmacology|September 12, 2019
Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid SupplementationElisabetta Teopompi, Patrizia Risé, Roberta Pisi, et al.
Chemmedchem|August 7, 2012
Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitorsMassimo Bertinaria, Mohammed Abrar Abdul Gaffar Shaikh, Carola Buccellati, et al.
Prostaglandins & Other Lipid Mediators|April 4, 2015
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT₂ receptorValérie Capra, Chiara Carnini, Maria Rosa Accomazzo, et al.
European Journal of Nutrition|November 20, 2015
Increased dietary levels of α-linoleic acid inhibit mammary tumor growth and metastasisMarianela Vara-Messler, Maria E Pasqualini, Andrea Comba, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 6, 2004
Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienesAntonio Di Gennaro, Chiara Carnini, Carola Buccellati, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administrationNadia Moretto, Paola Caruso, Raffaella Bosco, et al.
Pageof 3